CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 112 enrolled
Drug / intervention
Apollo™ Onyx™ Delivery Micro Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02378883
NCT02378883N/ACompleted
CompareCT.gov

Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study

Medtronic Neurovascular Clinical Affairs·interventional·Posted Mar 4, 2015·Updated Apr 29, 2019

In Brief

A clinical study evaluating Apollo™ Onyx™ Delivery Micro Catheter for Arteriovenous Malformations. Completed, enrolled 112 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the safety of the Apollo™ Onyx™ Delivery Microcatheter used for delivery of the Onyx™ Liquid Embolic System during brain arteriovenous malformation (AVM) embolization procedures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArteriovenous Malformations
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 4, 2015
Enrollment StartMay 18, 2015
Primary CompletionFeb 20, 2018
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 11.3 years ago

Interventions

Apollo™ Onyx™ Delivery Micro Catheterdevice